Danone said on Thursday that China will remain a key growth driver for the world's largest yoghurt maker, as medical nutrition and beverages categories remain robust, Reuters reported.
Danone price negotiations hit obstacles in Europe as market share lost
Danone logo. Credit: ricochet64 / Shutterstock

Medical nutrition, beverage categories remain robust.

Danone said on Thursday that China will remain a key growth driver for the world’s largest yoghurt maker, as medical nutrition and beverages categories remain robust, Reuters reported.

In 2022, demand for Danone’s Chinese vitamin drink brand Mizone was hit by the country’s no-COVID policy, but the company turned this around in 2023, making China its “number one driver”, Chief Financial Officer Juergen Esser said.

“We’re going to continue growing fast in China,” Esser told Reuters in an interview.

China’s aging population generates high interest in Danone’s medical nutrition business, which drives growth along with the beverages category, Esser said.

Meanwhile, the infant nutrition business continues to be under pressure due to declining birth rates, he added.

Danone beat expectations for first quarter volume/mix on Thursday, as a 6.9% increase in China drove a 1.2% rise for the group, with the Waters segment recording double-digit percentage sales growth on a like-for-like basis.

You can now read the most important #news on #eDairyNews #Whatsapp channels!!!

🇺🇸 eDairy News INGLÊS: https://whatsapp.com/channel/0029VaKsjzGDTkJyIN6hcP1K

Demand for dairy protein is running strong in the U.S. and around the world, and that provides opportunities — and challenges — for the U.S. dairy sector, according to CoBank’s outlook report for the year ahead.

You may be interested in

Related
notes

Most Read

Featured

Join to

Follow us

SUBSCRIBE TO OUR NEWSLETTER